The Shifting Sands of Science: AbbVie Steps Back from Calico's Longevity Quest

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A Breath of Fresh Air for Kids Living with IBS-C

The Unstoppable Ascent: How Linzess Propelled Ironwood to Staggering Heights

AbbVie's High-Stakes Forecast: A Boost That Still Left the Market Wanting More

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore

Soaring Horizons: Cystic Fibrosis Therapeutics Market Set to Skyrocket to $39.15 Billion by 2034

Unpacking Today's Top Stock Insights: AbbVie, Vertex, Veeva, and Vistra Under the Microscope

Breakthrough Hope: AbbVie's Next-Gen Alopecia Drug Shows Staggering Results in Late-Stage Trial